Biobeat introduces Patient Diary to enhance 24-hour blood pressure monitoring
Biobeat has launched a new Patient Diary feature within its FDA-cleared, cuffless 24-hour blood pressure monitoring platform, further advancing its mission to deliver more precise, personalised and actionable insights for hypertension care.
The Patient Diary allows patients to actively contribute context to their 24-hour blood pressure assessment by logging key daily factors directly in the Biobeat App. These include medication intake, physical activity, meals, sleep, mood, stress levels and notable health events. By capturing this information in real time, the diary transforms monitoring from a passive measurement process into an interactive, data-rich experience.
Combining continuous, validated blood pressure measurements with patient-reported inputs creates a more complete and meaningful clinical picture. Clinicians can now view blood pressure trends alongside the behaviours and events that may influence them,such as exercise, emotional stress, dietary choices or sleep quality, helping to reveal patterns that are often missed with traditional monitoring methods.
This added layer of context supports more confident, data-driven decision-making in both diagnosis and ongoing hypertension management. It reduces reliance on retrospective patient recall and fragmented reporting, enabling a clearer understanding of how individual patients respond to lifestyle factors, medications and treatment plans. For long-term hypertension care, this enables a more responsive, tailored and proactive approach.
Trusted by healthcare systems and research institutions worldwide, Biobeat’s wearable, cuffless technology continues to redefine how blood pressure is monitored beyond the clinic. The introduction of the Patient Diary strengthens Biobeat’s platform as a comprehensive, patient-centred solution that turns continuous data into clinically actionable insight.
By bringing patient experience and physiological data together, Biobeat takes another step toward truly personalised hypertension management, where every data point adds context, and every insight supports better clinical outcomes.